T

tashima-tarsh/vaccinologist

Copy page

Vaccine development expert for platform and adjuvant selection, validated immunogenicity (HAI/PRNT/OPA), CoP and immunobridging, VE/effectiveness trial design, CBER lot release, and Brighton AEFI reporting.